Platelet survival and sequestration patterns in thrombocytopenic disorders.
D000328:Adult; D000368:Aged; D001379:Azathioprine / Q000627:therapeutic use; D001792:Blood Platelets; D002470:Cell Survival; D002701:Chloramphenicol / Q000009:adverse effects; D002859:Chromium Isotopes; D003907:Dexamethasone / Q000627:therapeutic use; D004342:Drug Hypersensitivity / Q000097:blood; D005260:Female; D006207:Half-Life; D006801:Humans; D006971:Hypersplenism / Q000097:blood; D015470:Leukemia, Myeloid, Acute / Q000097:blood; D008180:Lupus Erythematosus, Systemic / Q000097:blood; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D011696:Purpura, Thrombocytopenic / Q000097:blood / Q000188:drug therapy; D011877:Radionuclide Imaging; D013156:Splenectomy; D013449:Sulfonamides / Q000009:adverse effects; D013921:Thrombocytopenia / Q000097:blood* / Q000139:chemically induced / Q000601:surgery
D002859:Chromium Isotopes; D013449:Sulfonamides; D002701:Chloramphenicol; D003907:Dexamethasone; D001379:Azathioprine; D011241:Prednisone